Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction

Completed

Conditions studied: Coronary Artery Disease

In brief

Single-center registry of patients treated with at least one Endeavor, zotarolimus-eluting, Stent as the primary treatment for acute coronary syndrome at the Washington Hospital Center, with the aim of assessing clinical success and safety at 30 days, 6 months and annually for up to 3 years post Endeavor Stent implantation.

Key facts

Study ID

NCT01003717

Run by

Rebecca Torguson

People needed

120

Starts

2009-10-01

Expected to finish

2013-10-01

Last updated by the study team

2020-01-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients, male or female, >18 years of age
• Patients presenting with acute coronary syndrome (ACS), where ACS is defined as ST segment deviation of >1mm or an elevation of the isoenzymes greater than 2x upper limit of normal
• Patients who received at least one Endeavor drug-eluting stent at the Washington Hospital Center

You may not qualify if…

• N/A

Where it is running

• Washington Hospital Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.